Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib - Concepedia

Concepedia

Publication | Open Access

Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

DOI Full Paper Access

140

Citations

30

References

2011

Year

Patrick G. Morris, Carol Chen, Richard M. Steingart, Martin Fleisher, Nancy U. Lin, Beverly Moy, Steven E. Come, Steven Sugarman, A. Abbruzzi, Robert Lehman,

Clinical Cancer Research

Abstract

In patients receiving ddAC → PTL, cTnIs are commonly detected. These elevations may precede changes in LVEF but, as assessed in this trial, do not predict CHF.

References

	Year	Citations

Page 1